Shom Goel, Laura Testa, Fernanda Damian, Pei Jye Voon, Daniele Assad Suzuki, Roberto Hegg, Dayana Ribeiro, Heloisa Rodrigues, José Bines, Iurie Vartolomei Bulat, Hua-Xin Gao, Surendra Chaudhary, Patrick Schnell, Ting Deng, Hao Zheng, Timothy A. Yap. "First disclosure of frontline treatment (1L tx) with the selective CDK4 inhibitor BGB-43395 in combination with letrozole for metastatic HR+/HER2− breast cancer (BC): A phase 1 safety expansion.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1066